
Biotech · South San Francisco, California
NewLimit
NewLimit is a biotechnology company developing medicines to treat age-related diseases by reprogramming the epigenome to restore regenerative potential in aged and diseased cells. It uses functional genomics, pooled perturbation screens, and machine learning to study epigenetic aging at scale.
Work at NewLimit?
- Location
- South San Francisco
- On-site · 10 roles
- Team size
- 11-50
- Founded 2022
- Total raised
- $610M
- Series C · last round Jun '26
- Salary range
- $75–240k
- 9 of 10 roles
Open positions · 10
About NewLimit
NewLimit is a biotechnology company aiming to radically extend human healthspan. It develops medicines to treat age-related diseases by reprogramming the epigenome, a therapeutic approach intended to restore regenerative potential in aged and diseased cells. The company leverages functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease. It conducts experiments at unprecedented scale to accelerate discovery and development.
Funding
$610Mtotal raised
- Jun 2026 · Series C$435M
- Oct 2025 · Funding round$45M
- May 2025 · Series B$130M
Company at a glance
The team at NewLimit
11-50 peopleSee everyone on LinkedIn
Location
Life at NewLimit
Frequently asked questions
Of 10 open roles, NewLimit has 10 on-site positions.
NewLimit is based in South San Francisco, California.
Ask your AI about NewLimit
Connect Clera once, then ask what they're hiring for.
Ask about this company
What is NewLimit hiring for on Clera (https://www.getclera.com/companies/newlimit)? Tell me which of those roles fit my profile, and tell Clera I'm interested in the best one.
Not connected yet? Takes a minute
https://mcp.getclera.comSign in with your Clera account. MCP docs
Companies similar to NewLimit
Arceus is building the legal infrastructure layer for modern companies by combining experienced attorneys with intelligent technology to deliver high-quality legal services at the speed growing businesses demand. The company addresses a critical gap between legal teams' need to move faster across commercial, product, privacy, procurement, and operational work and the outdated tools and delivery models currently available. By transforming legal judgment and playbooks into scalable, innovative products, Arceus aims to reinvent how companies receive legal support. Operating in a trillion-dollar market with significant demand for its solutions, the company is positioned to fundamentally change the way modern businesses access and manage legal expertise.
We're building the first AI-native go-to-market agency in the DACH region. Since 2024, we've grown to over €5M ARR and a team of 30+, working with more than 200 leading B2B tech companies.
Augustus is building the global dollar bank. Moving dollars across borders still runs on correspondent banking, a chain of intermediaries that is slow, opaque, and expensive. Augustus replaces it with programmable USD and EUR accounts, direct clearing and settlement, and an AI-native core banking platform built from scratch. The moat is the license. Augustus holds OCC conditional approval for a US national bank charter, which is rare and very hard to replicate, and euro clearing is live today for customers including Kraken. $180M Series B at a $1B valuation, led by Tiger Global with QED, plus operators from Nubank, Ramp, Circle, Revolut, and Coinbase. Fewer than 50 people, in NYC and Berlin.

